Expanding Access to Patients in Need Around the World
Interview with Gregg H. Alton, Ph.D., Executive VP, Corporate and Medical Affairs, Gilead Sciences, Inc.
Part 2: Global access program
88 views
00:08:42 - Uploaded by Song Essinova, LLC on June 20, 2010
At BioPacific2010, Gregg Alton spoke to Essinova host, BeiBei Song about Gilead's HIV/AIDS product portfolio, the company's pipeline status, its global access program and initiatives in Asia.
Tags: CABS, BioPacific 2010, Gregg Alton, Gilead, HIV, AIDS, Viread, Truvada, Atripla, hepatitis C
RELATED
COMMENTS
There are 0 comments. You must be logged in to comment.
-
Expanding Access to Patients in Need Around the World
-
China's Healtcare Reform
-
H1N1 Influenza Status Update
-
Asthma: What Brought on the Epidemic?
-
Can We Prevent Asthma?
-
Dean Ornish on Healing
-
The Evolving Treatment Paradigm in Myeloma
-
HealthMap: Digital Disease Detection
-
Nathan Wolfe's Jungle Search for Viruses
